Dual Roles of miR-374a by Modulated C-Jun Respectively Targets CCND1-inducing PI3K/AKT Signal and PTEN-suppressing WNT/Β-Catenin Signaling in Non-Small-Cell Lung Cancer

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-017-0103-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PAQR3 Inhibits Proliferation via Suppressing PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer

Archives of Medical Science
Medicine
2018English

miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer

Cancer Research
Cancer ResearchOncology
2013English

miR-1269b Drives Cisplatin Resistance of Human Non-Small Cell Lung Cancer via Modulating the PTEN/PI3K/AKT Signaling Pathway

OncoTargets and Therapy
OncologyPharmacology
2020English

Hsa-miR-326 Targets CCND1 and Inhibits Non-Small Cell Lung Cancer Development

Oncotarget
Oncology
2016English

miR-650 Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion by Targeting ING4 Through WNT-1/Β-Catenin Pathway

Oncology Letters
Cancer ResearchOncology
2019English

MicroRNA-545 Targets ZEB2 to Inhibit the Development of Non‑small Cell Lung Cancer by Inactivating WNT/Β-Catenin Pathway

Oncology Letters
Cancer ResearchOncology
2019English

miR-181 Regulates Cisplatin-Resistant Non-Small Cell Lung Cancer via Downregulation of Autophagy Through the PTEN/PI3K/AKT Pathway

Oncology Reports
MedicineCancer ResearchOncology
2018English

Circ-Sox4 Promotes Non-Small Cell Lung Cancer Progression by Activating the WNT/Β-Catenin Pathway

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

miR‑338‑3p Inhibits A549 Lung Cancer Cell Proliferation and Invasion by Targeting AKT and Β‑catenin Signaling Pathways

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy